Sonoma Pharmaceuticals, Inc. (SNOA)

NASDAQ: SNOA · Real-Time Price · USD

2.840

-0.320 (-10.13%)

At close: Nov 20, 2024, 4:00 PM

2.860

+0.020 (0.70%)

Pre-market: Nov 21, 2024, 7:27 AM EST

Sonoma Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for SNOA.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for SNOA.

Recommendation Trends

Rating	Jun '23	Jul '23	Aug '23
Strong Buy	0	0	0
Buy	0	0	0
Hold	1	1	1
Sell	0	0	0
Strong Sell	0	0	0
Total	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jeff Cohen Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Initiates $65	Strong Buy	Initiates	$65	+2,188.73%	Sep 5, 2023
Jason Kolbert Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Mar 6, 2018
Jason Kolbert Maxim Group	Maxim Group	Strong Buy Maintains $1,800 → $1,980	Strong Buy	Maintains	$1,800 → $1,980	+69,618.31%	Nov 10, 2017

More Analyst Ratings

Financial Forecast

Revenue This Year

17.32M

from 12.74M

36.00%

from 12.74M

Revenue Next Year

21.70M

from 17.32M

25.26%

from 17.32M

EPS This Year

-4.08

from -10.64

EPS Next Year

-1.84

from -4.08

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026
Revenue	17.93M	18.63M	12.63M	13.27M	12.74M	17.32M	21.70M
Revenue Growth	-5.49%	3.91%	-32.21%	5.10%	-4.05%	36.00%	25.26%
EPS	-44.79	-39.58	-38.34	-30.35	-10.64	-4.08	-1.84
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025
High	17.8M	22.3M
Avg	17.3M	21.7M
Low	16.6M	20.8M

Revenue Growth

Revenue Growth	2024	2025
High	40.0%	28.9%
Avg	36.0%	25.3%
Low	30.7%	20.4%

EPS Forecast

EPS	2024	2025
High	-4.20	-1.89
Avg	-4.08	-1.84
Low	-3.92	-1.76

EPS Growth

EPS Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.